24小时热门版块排行榜

>论坛更新日志 (3904)
>虫友互识 (616)
>文献求助 (245)
>导师招生 (159)
>休闲灌水 (95)
>招聘信息布告栏 (90)
>考博 (76)
>博后之家 (67)
>论文投稿 (47)
>硕博家园 (32)
>教师之家 (27)
>考研 (24)
>晶体 (23)
>论文道贺祈福 (22)
>公派出国 (21)
>基金申请 (17)

返回列表

【悬赏金币】回答本帖问题，作者Alfieder将赠送您 10 个金币

当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖

Alfieder

金虫 (初入文坛)

应助: 0 (幼儿园)
金币: 1502.5
帖子: 23
在线: 16.5小时
虫号: 967810
注册: 2010-03-11
性别: GG
专业: 系统生物学

[求助] 除了语言方面，编辑还让我修改些什么？还有什么具体要求？已有4人参与

Ref.: JCB-15-900
Title: Pharmacokinetics study of 3,4-divanillyltetrahydrofuran in rats by ultra-flow liquid chromatography-tandem mass spectrometry
Corresponding Author: Mr. Xiaobing Cui

Dear Mr. Cui,

On behalf of the editor handling your manuscript, Dr. David S. Hage, I am writing to you in reference to your manuscript entitled:

As you will see from the comments appended below, a major revision has been requested. I should be grateful if you would revise the paper in accordance with these recommendations and submit your revised manuscript within 60 days.

Please submit your suitably revised manuscript online by logging onto https://ees.elsevier.com/chromb/

The manuscript record can be found in the "Submissions Needing Revision" menu.

Please upload the following items:

1. A detailed, point-by-point response to each comment raised in the review. Please list each comment from this review, one by one, and provide your reply below each comment, including the actual changes made in the manuscript and their location (or the reason why no change was made). Useful information in the reply letter that answers a reviewer's comment needs to be included in the manuscript as well. This document should be uploaded as "Response to Reviewer Comments".

2. A complete, editable, electronic copy (i.e. Word, WordPerfect, RTF, or LaTex) of the revised manuscript in which all the changes made in response to these comments are clearly indicated with red highlight. This document should be uploaded as "Manuscript". Please do NOT upload any other copies of the manuscript.

3. Figures should be uploaded individually as TIF or EPS files with the figure number clearly indicated in the file name.

Please note that this journal offers a new, free service called AudioSlides: brief, webcast-style presentations that are shown next to published articles on ScienceDirect (see also https://www.elsevier.com/audioslides). If your paper is accepted for publication, you will automatically receive an invitation to create an AudioSlides presentation.

Please note that we allow 60 days for the first author revision and 30 days for any additional author revisions that are required.

Thank you for your cooperation.

Journal of Chromatography B features the Interactive Plot Viewer, see: https://www.elsevier.com/interactiveplots. Interactive Plots provide easy access to the data behind plots. To include one with your article, please prepare a .csv file with your plot data and test it online at https://authortools.elsevier.com/interactiveplots/verification before submission as supplementary material.

We look forward to receiving your revised manuscript.

Kind regards,

David S. Hage, PhD
Editor
Journal of Chromatography B

Comments:

Editor: This paper needs some revisions in its English and grammar usage before I can send it to external reviewers. I recommend that the authors have someone who is an expert or proficient in English writing to go carefully through this article to proofread and correct it as the authors' revise this paper.

******************************************
Please note that the editorial process varies considerably from journal to journal. To view a sample editorial process, please click here:
https://ees.elsevier.com/eeshelp/sample_editorial_process.pdf

For further assistance, please visit our customer support site at https://help.elsevier.com/app/answers/list/p/7923. Here you can search for solutions on a range of topics, find answers to frequently asked questions and learn more about EES via interactive tutorials. You will also find our 24/7 support contact details should you need any further assistance from one of our customer support representatives.

回复此楼